VIVA 2019: 4-Year Data Shows Success For Medtronic’s In.Pact Admiral DCB

An ongoing trial of Medtronic’s In.Pact Admiral paclitaxel-coated balloon found a four-year survival rate in line with what would be expected for the patient population and a relatively low rate of complications.